Jordan E Lake1. 1. University of Texas Health Science Center at Houston, 6431 Fannin St., MSB 2.112, Houston, TX, 77030, USA. Jordan.E.Lake@uth.tmc.edu.
Abstract
PURPOSE OF REVIEW: The aim of this review is to summarize knowledge of the prevalence, relevant physiology, and consequences of obesity and visceral adiposity in HIV-infected adults, including highlighting gaps in current knowledge and future research directions. RECENT FINDINGS: Similar to the general population, obesity prevalence is increasing among HIV-infected persons, and obesity and visceral adiposity are associated with numerous metabolic and inflammatory sequelae. However, HIV- and antiretroviral therapy (ART)-specific factors may contribute to fat gain and fat quality in treated HIV infection, particularly to the development of visceral adiposity, and sex differences may exist. Obesity and visceral adiposity commonly occur in HIV-infected persons and have significant implications for morbidity and mortality. Future research should aim to better elucidate the HIV- and ART-specific contributors to obesity and visceral adiposity in treated HIV infection, with the goal of developing targeted therapies for the prevention and treatment of obesity and visceral adiposity in the modern ART era.
PURPOSE OF REVIEW: The aim of this review is to summarize knowledge of the prevalence, relevant physiology, and consequences of obesity and visceral adiposity in HIV-infected adults, including highlighting gaps in current knowledge and future research directions. RECENT FINDINGS: Similar to the general population, obesity prevalence is increasing among HIV-infectedpersons, and obesity and visceral adiposity are associated with numerous metabolic and inflammatory sequelae. However, HIV- and antiretroviral therapy (ART)-specific factors may contribute to fat gain and fat quality in treated HIV infection, particularly to the development of visceral adiposity, and sex differences may exist. Obesity and visceral adiposity commonly occur in HIV-infectedpersons and have significant implications for morbidity and mortality. Future research should aim to better elucidate the HIV- and ART-specific contributors to obesity and visceral adiposity in treated HIV infection, with the goal of developing targeted therapies for the prevention and treatment of obesity and visceral adiposity in the modern ART era.
Authors: Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; Ron Blankstein; Raymond Y Kwong; Allison B Goldfine; Michael Jerosch-Herold; João A C Lima; Jingzhong Ding; Matthew A Allison Journal: JACC Cardiovasc Imaging Date: 2014-11-05
Authors: Kristine M Erlandson; Kunling Wu; Susan L Koletar; Robert C Kalayjian; Ronald J Ellis; Babafemi Taiwo; Frank J Palella; Katherine Tassiopoulos Journal: J Infect Dis Date: 2017-03-15 Impact factor: 5.226
Authors: Bianca Yuh; Janet Tate; Adeel A Butt; Kristina Crothers; Matthew Freiberg; David Leaf; Mary Logeais; David Rimland; Maria C Rodriguez-Barradas; Christopher Ruser; Amy C Justice Journal: Clin Infect Dis Date: 2015-03-11 Impact factor: 9.079
Authors: Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein Journal: Proc Natl Acad Sci U S A Date: 2009-08-24 Impact factor: 11.205
Authors: Lois J Conley; Timothy J Bush; Adam W Rupert; Irini Sereti; Pragna Patel; John T Brooks; Jason V Baker Journal: AIDS Date: 2015-10-23 Impact factor: 4.177
Authors: S Adrian; A Scherzinger; A Sanyal; J E Lake; J Falutz; M P Dubé; T Stanley; S Grinspoon; J-C Mamputu; C Marsolais; T T Brown; K M Erlandson Journal: J Frailty Aging Date: 2019
Authors: R R Cook; J A Fulcher; N H Tobin; F Li; D Lee; C Woodward; M Javanbakht; R Brookmeyer; S Shoptaw; R Bolan; G M Aldrovandi; P M Gorbach Journal: HIV Med Date: 2019-12-27 Impact factor: 3.180
Authors: Lindsay T Fourman; Takara L Stanley; Isabel Zheng; Chelsea S Pan; Meghan N Feldpausch; Julia Purdy; Julia Aepfelbacher; Colleen Buckless; Andrew Tsao; Kathleen E Corey; Raymond T Chung; Martin Torriani; David E Kleiner; Colleen M Hadigan; Steven K Grinspoon Journal: Clin Infect Dis Date: 2021-06-15 Impact factor: 9.079
Authors: R C Basil; T T Brown; S Haberlen; L H Rubin; M Plankey; J T Becker; J E Lake; F J Palella; S Sarkar Journal: HIV Med Date: 2020-09-24 Impact factor: 3.180